Latest Als News

SQX Resources has validated and surpassed historical gold grades at its Red Bird Project in Arizona, with assays reaching 49.2 g/t Au. A maiden drilling campaign is planned for January 2026 to explore this promising gold system further.

Western Yilgarn NL has significantly expanded its exploration footprint at the Ida Holmes Junction Project to target high-grade gallium mineralisation and secured critical land access for drilling at its West Julimar Bauxite Project in Western Australia.

Metal Bank Limited is advancing its Western Australia gold strategy with significant resource development at Livingstone and a binding agreement to acquire Hastings Technology Metals’ WA gold assets, while also progressing critical minerals projects in Queensland and Saudi Arabia.

Alara Resources has reported a significant production uplift at its Al Wash-hi Majaza mine following the commissioning of two new tailings filter presses, alongside securing the Daris 3A5 mining license and initiating drilling at the Al Mansur Prospect.

Kaili Resources has completed a second drilling program targeting rare earth elements in South Australia, revealing encouraging preliminary results that underscore the potential of its Limestone Coast projects.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Solis Minerals reports encouraging assay results from its Peruvian copper-gold projects alongside a $5.9 million capital raise to accelerate exploration and acquisition activities.

Asian Battery Metals PLC advances its flagship Oval Cu-Ni-PGE discovery with Phase 3 drilling confirming mineralisation extensions and strong copper recoveries, while expanding its portfolio through a strategic option on the Maikhan Uul Cu-Au project.

MetalsTech Limited has strengthened its balance sheet with a $3.3 million strategic placement and cleared debt, pushing forward the Pre-Feasibility Study for its Sturec Gold Mine in Slovakia. The study is on track for completion by year-end, aiming to unlock significant project value.

Invictus Energy has secured National Project Status for its Cabora Bassa gas project in Zimbabwe and signed a major funding deal with Al Mansour Holdings, setting the stage for high-impact drilling in 2026.

Alara Resources has dispatched its 28th shipment of copper concentrate from its Oman mine, marking the highest monthly shipment volume to date with over 4,000 wet metric tonnes shipped in October 2025.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.